Skip to content

13F-HR filed by SECTOR GAMMA AS

SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-08, with 33 holding rows worth $425,417,000.

Accession
0001567619-22-002821
Filed
2022-02-08
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 33 entries on the cover page, a total value of $425,417,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $425,417,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Merck & Co.,Inc.58933Y105COM475,804$36,466,000thousands by filing date
INCYTE CORP COM45337C102Stock378,852$27,808,000thousands by filing date
CARDINAL HEALTH INC14149Y108COM496,680$25,574,000thousands by filing date
Bristol-Myers Squibb Company110122108COM348,591$21,735,000thousands by filing date
Gilead Sciences,Inc.375558103COM297,055$21,569,000thousands by filing date
CVS Health Corporation126650100COM206,162$21,268,000thousands by filing date
Boston Scientific Corporation101137107COM499,530$21,220,000thousands by filing date
Medtronic PlcG5960L103COM204,268$21,132,000thousands by filing date
BECTON DICKINSON & CO075887109COM75,647$19,024,000thousands by filing date
Pfizer Inc.717081103COM285,403$16,853,000thousands by filing date
BIOGEN INC COM09062X103Stock66,599$15,978,000thousands by filing date
Elevance Health, Inc.036752103COM34,402$15,947,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock183,146$15,091,000thousands by filing date
BRUKER CORP116794108COM162,768$13,658,000thousands by filing date
ORGANON & CO COMMON STOCK68622V106Stock431,709$13,146,000thousands by filing date
NUVASIVE INC670704105COM240,691$12,631,000thousands by filing date
QIAGEN NVN72482123SHS NEW196,845$10,941,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM113,548$10,032,000thousands by filing date
ELANCO ANIMAL HEALTH INC COM28414H103Stock345,230$9,798,000thousands by filing date
Cigna Corporation125523100COM41,500$9,530,000thousands by filing date
BIO RAD LABS INC090572207CL A11,639$8,794,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM39,069$8,580,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW23,377$7,345,000thousands by filing date
DENTSPLY SIRONA INC24906P109COM114,816$6,406,000thousands by filing date
IONIS PHARMACEUTICALS INC COM462222100Stock209,537$6,376,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock45,238$5,866,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM98,904$4,207,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK1,469,604$3,894,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM26,106$3,829,000thousands by filing date
PATTERSON COS INC703395103COM122,947$3,608,000thousands by filing date
BIONTECH SE SPONSORED ADS09075V102ADR13,032$3,360,000thousands by filing date
NOVAVAX INC670002401COM NEW13,346$1,909,000thousands by filing date
VIR BIOTECHNOLOGY INC92764N102COM44,000$1,842,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001567619-22-002821this filing2022-02-08acceptance time not in the bulk data set